BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2007
View Archived Issues
Novartis discovers a potent NPM-ALK kinase inhibitor
Read More
Hivenyl significantly reduces atopic dermatitis itch severity without sedation
Read More
VASTox joins European consortium to research new treatments for cancer
Read More
Pivotal study evaluates Aastrom's TRCs for osteonecrosis of the femoral head
Read More
Cervarix compared to Gardasil in new phase III study
Read More
Archemix and Merck KGaA sign aptamer agreement in cancer
Read More
FDA grants orphan drug status to VQD-001 for cutaneous leishmaniasis
Read More
Two phase I trials cleared to begin for Lymphoseek in prostate and colon cancers
Read More
Positive preclinical results with Endocyte's folate receptor-targeted immunotherapy
Read More
Lipsovir cold sore program makes progress
Read More
1207 shows no clear anesthetic effect in phase I study
Read More
Butyrylcholinesterase studied as chemical defense product in new phase I trial
Read More
Adherex acquires GSK's options to eniluracil
Read More
Enrollment completed in study of AZ-004 in agitated schizophrenic patients
Read More
Data on nitroflurbiprofen sets stage for clinical trials in DMD
Read More
Neuroprotection by humanin and one of its derivatives: an update
Read More
INNO-406 found effective in animal models of CNS Ph+ leukemia
Read More
Alimta launched in Japan for malignant pleural mesothelioma
Read More
Cipralex approved in Europe for OC
Read More
Full European approval for Sutent in advanced renal cell carcinoma
Read More
New therapeutic agents for ocular disorders disclosed in recent patent literature
Read More
Recent patents report novel analgesic agents
Read More
New agents for treating gastrointestinal disorders disclosed in recent patents
Read More
Inovelon approved in E.U. for Lennox-Gastaut syndrome
Read More
